创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

赵鹏飞, 施明杰, 黄永焯. 基于营养转运体或信号受体介导的仿生递药策略在脑部肿瘤治疗中的应用进展[J]. 药学进展, 2018, 42(11): 804-815.
引用本文: 赵鹏飞, 施明杰, 黄永焯. 基于营养转运体或信号受体介导的仿生递药策略在脑部肿瘤治疗中的应用进展[J]. 药学进展, 2018, 42(11): 804-815.
ZHAO Pengfei, SHI Mingjie, HUANG Yongzhuo. Application Progress in Biomimetic Drug Delivery Strategies Mediated by Nutrient Transporters or Signal Receptors for Brain Tumor Therapy[J]. Progress in Pharmaceutical Sciences, 2018, 42(11): 804-815.
Citation: ZHAO Pengfei, SHI Mingjie, HUANG Yongzhuo. Application Progress in Biomimetic Drug Delivery Strategies Mediated by Nutrient Transporters or Signal Receptors for Brain Tumor Therapy[J]. Progress in Pharmaceutical Sciences, 2018, 42(11): 804-815.

基于营养转运体或信号受体介导的仿生递药策略在脑部肿瘤治疗中的应用进展

Application Progress in Biomimetic Drug Delivery Strategies Mediated by Nutrient Transporters or Signal Receptors for Brain Tumor Therapy

  • 摘要: 血脑屏障(BBB)限制了绝大多数药物进入脑部,从而成为中枢神经系统疾病治疗的主要障碍。基于仿生策略的脑部疾病靶向递药系统,是近年来极受研究者关注的具有广阔应用前景的药物递送系统。在脑部肿瘤病理环境中,BBB的血管上皮组织或肿瘤细胞高表达营养转运体及特定信号受体,以支撑肿瘤快速增殖的需要。综述近年来基于营养物质转运体及信号受体途径介导的脑部肿瘤仿生靶向递药研究进展。

     

    Abstract: The blood-brain barrier (BBB) restricts the entry of most drugs into the brain, making it a major therapeutic obstacle to the central nervous system diseases. The brain-targeting biomimetic drug delivery strategies have recently been extensively investigated due to its promising prospects. In the brain tumor microenvironments, some specific nutrient transporters and signal receptors are overexpressed in the blood epithelium or tumor cells to support the rapid growth of tumor. This article reviewed the research progress of brain-targeting biomimetic delivery strategies mediated by nutrient transports and signal receptors related pathways in recent years and their applications in brain cancer therapy.

     

/

返回文章
返回